This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2024 Jun;47(3):94.

doi: 10.18773/austprescr.2024.019.

Lipid-lowering therapy in patients with a 'normal' LDL-C

No authors listed

PMID: 38962386
PMCID: PMC11216912
DOI: 10.18773/austprescr.2024.019

Comment

Lipid-lowering therapy in patients with a 'normal' LDL-C

No authors listed. Aust Prescr. 2024 Jun.

. 2024 Jun;47(3):94.

doi: 10.18773/austprescr.2024.019.

PMID: 38962386
PMCID: PMC11216912
DOI: 10.18773/austprescr.2024.019

No abstract available

Keywords: LDL cholesterol; ezetimibe; hypercholesterolaemia; statins.

PubMed Disclaimer

Comment on

Managing hypercholesterolaemia.
Nelson AJ, Nicholls SJ. Nelson AJ, et al. Aust Prescr. 2024 Feb;47(1):7-14. doi: 10.18773/austprescr.2024.006. Aust Prescr. 2024. PMID: 38444897 Free PMC article. Review.

Similar articles

Role of colesevelam in combination lipid-lowering therapy.
Jones MR, Nwose OM. Jones MR, et al. Am J Cardiovasc Drugs. 2013 Oct;13(5):315-23. doi: 10.1007/s40256-013-0037-0. Am J Cardiovasc Drugs. 2013. PMID: 23913404 Free PMC article. Review.
Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe.
Daskalopoulou SS, Mikhailidis DP. Daskalopoulou SS, et al. Curr Med Res Opin. 2006 Mar;22(3):511-28. doi: 10.1185/030079906X89856. Curr Med Res Opin. 2006. PMID: 16574035 Review.
Impact of statin therapy on LDL and non-HDL cholesterol levels in subjects with heterozygous familial hypercholesterolaemia.
Climent E, Marco-Benedí V, Benaiges D, Pintó X, Suárez-Tembra M, Plana N, Lafuente H, Ortega-Martínez de Victoria E, Brea-Hernando Á, Vila À, Civeira F, Pedro-Botet J. Climent E, et al. Nutr Metab Cardiovasc Dis. 2021 May 6;31(5):1594-1603. doi: 10.1016/j.numecd.2021.01.014. Epub 2021 Jan 28. Nutr Metab Cardiovasc Dis. 2021. PMID: 33744038
Monascus purpureus for statin and ezetimibe intolerant heterozygous familial hypercholesterolaemia patients: A clinical study.
Stefanutti C, Mazza F, Mesce D, Morozzi C, Di Giacomo S, Vitale M, Pergolini M. Stefanutti C, et al. Atheroscler Suppl. 2017 Nov;30:86-91. doi: 10.1016/j.atherosclerosissup.2017.05.021. Atheroscler Suppl. 2017. PMID: 29096866
Reduction of C-reactive protein, low-density lipoprotein cholesterol, and its relationship with cardiovascular events of different lipid-lowering therapies: A systematic review and meta-analysis of randomized controlled trials.
Yang W, Cai X, Lin C, Lv F, Zhu X, Han X, Ji L. Yang W, et al. Medicine (Baltimore). 2022 Sep 16;101(37):e30563. doi: 10.1097/MD.0000000000030563. Medicine (Baltimore). 2022. PMID: 36123891 Free PMC article.

See all similar articles

References

1. Nelson AJ, Nicholls SJ. Managing hypercholesterolaemia. Aust Prescr 2024;47:7-14. 10.18773/austprescr.2024.006 - DOI - PMC - PubMed
1. Commonwealth of Australia. Australian Guideline for assessing and managing cardiovascular disease risk. Department of Health and Aged Care; 2023. https://www.cvdcheck.org.au/ [cited 2024 Apr 23] - PMC - PubMed
1. Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, et al. ESC Scientific Document Group . 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J 2020;41:111-88. 10.1093/eurheartj/ehz455 - DOI - PubMed
1. Mihaylova B, Emberson J, Blackwell L, Keech A, Simes J, Barnes EH, et al. Cholesterol Treatment Trialists’ (CTT) Collaborators . The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet 2012;380:581-90. 10.1016/S0140-6736(12)60367-5 - DOI - PMC - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Europe PubMed Central
- PubMed Central